about
Early management of patients with acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/heart failure society of America acute heart failure working groupChallenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugsSoluble ST2 as a Diagnostic and Prognostic Marker for Acute Heart Failure Syndromes.Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendations.Reducing blood culture contamination in the emergency department: an interrupted time series quality improvement study.Reliability of Clinical Assessments in Older Adults With Syncope or Near Syncope.The use of noninvasive ventilation in emergency department patients with acute cardiogenic pulmonary edema: a systematic review.Clinical characteristics of emergency department heart failure patients initially diagnosed as non-heart failure.Markers of diuretic resistance in emergency department patients with acute heart failureValidation of the Confusion Assessment Method for the Intensive Care Unit in older emergency department patients.Assessment of dyspnea early in acute heart failure: patient characteristics and response differences between likert and visual analog scales.Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea.A pilot study to evaluate learning style-tailored information prescriptions for hypertensive emergency department patients.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.International variations in the clinical, diagnostic, and treatment characteristics of emergency department patients with acute heart failure syndromes.Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study.A clinical prediction model to estimate risk for 30-day adverse events in emergency department patients with symptomatic atrial fibrillationImpact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities.Incidence of emergency department visits for ST-elevation myocardial infarction in a recent six-year period in the United StatesAssessment of the Framingham risk factors among ED patients with newly diagnosed atrial fibrillationEarly management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group.Impaired arousal at initial presentation predicts 6-month mortality: an analysis of 1084 acutely ill older patients.Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspnea.Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic reviewThe AFFORD clinical decision aid to identify emergency department patients with atrial fibrillation at low risk for 30-day adverse events.Atrial fibrillation and flutter outcomes and risk determination (AFFORD): design and rationaleTimeliness of interfacility transfer for ED patients with ST-elevation myocardial infarction.The burden of acute heart failure on U.S. emergency departmentsSelf-care Barriers Reported by Emergency Department Patients With Acute Heart Failure: A Sociotechnical Systems-Based Approach.Prevalence of validated risk factors for developing atrial fibrillation--can we identify high-risk ED patients?Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: identifying patients who do not respond to standard therapyHealth literacy and mortality: a cohort study of patients hospitalized for acute heart failure.Bayesian adaptive trial design in acute heart failure syndromes: moving beyond the mega trial.Elevated urinary neutrophil gelatinase-associated lipocalcin after acute heart failure treatment is associated with worsening renal function and adverse events.Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision Tool.Critical review and recommendations for nesiritide use in the emergency department.A comparison of criterion standard methods to diagnose acute heart failure.Incidence of Hypertension-Related Emergency Department Visits in the United States, 2006 to 2012
P50
Q27000455-F66288F1-73D8-4612-9DD8-070059659029Q28085736-84C730F1-DF45-4974-B292-05199D51AD7FQ30458086-6BC22EBF-6C75-4A8A-93DD-AFFD729D6809Q30479678-DD81F67E-9904-48C4-8A22-DC3AB513026BQ30538745-BDC8112E-AAB2-405F-91FD-1189A67812D7Q33166995-B4CA5A43-ED3E-460B-B729-A04200B69C0AQ33255395-D5157F36-CC8C-4B10-9891-3D3D372145B2Q33263604-481EF67F-9F84-418C-8FF7-E0DB20F1185BQ33649713-AF7C2D51-3A9B-4522-9BDB-D3021F2F7E34Q33665124-A6B0382B-314B-4E38-B4C3-F37DB597297EQ33929963-8F87D31D-795C-4E6D-9B91-AC70DA2A83CFQ33976462-0CBFC866-F97F-437C-AC57-62DCC31792D8Q34055137-7E6D2DB3-CB8B-43C9-A704-3500685A6D83Q34139611-B6C171BB-DF71-4919-B831-91E695A79F95Q34308342-FDD3EFA5-41FA-4E65-BE7A-1C172EDB1E7CQ34327192-A279085C-EC96-4F77-9E82-E6F5E6181382Q34434368-4EE8AC3A-8FC9-4D2E-AC05-507A7EA7171BQ34487258-4D19CB54-0501-457E-A95F-53C77597A65FQ34518561-BBF81E0D-D432-4B61-9FA5-7F89AC9ECC6BQ34621765-99870F60-B7F3-442F-A573-DDCFEF352F96Q34772119-19BF36FF-0FA7-4C14-BB3B-9B5FE685F4A8Q34883854-DD93145A-C70F-47C4-9096-B7D0DBFDEEFBQ35057622-3427B3B7-E327-4F34-ACBC-9513D5BC3754Q35077871-F4C060C1-8968-4A35-A370-4C56393B843DQ35092503-C1ABA73D-D55A-4AD4-904C-389A10FF60AEQ35132420-7841CDB3-67A7-4C03-85EB-B8169957C65AQ35137611-00937CAB-640E-4BE1-B443-AE71471551C7Q35202935-6D7A7F31-EA1F-4A9B-8833-78569177E543Q35269703-C7B9F440-D383-4D07-BCDD-E85769AF6F7DQ35598631-90296C81-7C86-46CC-807C-3029368272DCQ35772221-9C778BBA-5306-492D-B478-835960CC2F2DQ35785751-1093DE74-D7CE-409A-A722-C9C7BFA0866FQ35911334-89E59B9F-CA61-4361-8400-7E8D1335F206Q36141353-36068715-A3DD-4D67-9002-CEAEA2BB6E37Q36158310-9FFC5BAF-7C24-4CFE-BC09-5936B2D9C955Q36178408-EA3DC50F-745E-4B4E-B06B-8AC53FA9F599Q36223832-B7009CE5-BA8F-4CF1-8604-0C753547B42AQ36267520-424192FF-82A6-4DAB-99BE-61AA3F32B880Q36281124-60DBFC6C-AD86-4A8B-9884-6865186C206DQ36289199-BC79614D-B140-4B81-A3AF-C99ECA9809AB
P50
description
emergency medicine physician
@en
name
Alan B. Storrow
@en
type
label
Alan B. Storrow
@en
prefLabel
Alan B. Storrow
@en